MedTrace Logo

Family Empathic Behaviour Versus Nurse Empathic Behaviour

NCT02082951 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2014-03-10

No results posted yet for this study

Summary

The objective was to compare the frequency and intensity of symptoms of anxiety in patients of preoperative cardiac surgery who received empathic behaviour from nurse or family or those who received no specific type of empathic behaviour. This is a randomized clinical trial. The sample consisted of 66 patients in preoperative of cardiac surgery, who were divided in three groups: empathic behaviour by nurses, without specific empathic behaviour and by family. Anxiety was assessed at two time points: before and after the intervention. The instrument used was developed and validated, comprising 19 defining characteristics of the nursing diagnosis anxiety. The hypothesis is that the group who received empathic behaviour from nurse or family will reduce the anxiety.

Conditions

Interventions

BEHAVIORAL

Empathic behaviour by nurses.

The empathic behaviour in group 1 was performed by a trained nurse.

BEHAVIORAL

Empathic behaviour by family.

Considered the empathic behaviour performed by family as a hospital visit with greater than 45 minutes duration, a person with whom the patient had a good relationship, he considered it to be important and welcome. It is emphasized that these families did not have any prior training and after the visit, patients were asked about how the visit had been seeking to detect the presence of any conversations that have been unpleasant for patients and, if present, the patients were excluded from the study.

Sponsors & Collaborators

  • Juliana de Lima Lopes

    lead OTHER

Principal Investigators

  • Cinthia C Assis, PhD · Federal University

  • Luiz Antônio Nogueira-Martins, PhD · Federal University of São Paulo

  • Alba Lucia BL Barros, PhD · Federal University of SãoPaulo

  • Juliana L Lopes, PhD · Federal University of São Paulo

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2012-11-30
Completion
2012-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02082951 on ClinicalTrials.gov